LUMA Vision Advances Cardiac Care with VERAFEYE™ 4D Navigation Technology

Revolutionary Advances in Cardiac Care by LUMA Vision

In a groundbreaking development for cardiac care, LUMA Vision Ltd., a frontrunner in 4D navigation and imaging for cardiac procedures, has successfully performed 15 persistent atrial fibrillation (AF) ablation procedures utilizing its advanced VERAFEYE™ technology. This achievement culminated in a clinical study in collaboration with CardioFocus, Inc., aimed at refining catheter ablation therapy methods.

The VERAFEYE™ system stands out for its prowess in combining high-resolution 2D and 4D imaging with advanced navigation capabilities. This unique integration allows for real-time visualization of the heart in motion, delivering unmatched anatomical accuracy crucial for complex procedures. By employing automated digital anatomical modeling, it provides clinicians with a comprehensive view of the atria, thereby enhancing decision-making during procedures.

Dr. Ante Anic, Director of Electrophysiology at KBC Split, Croatia, emphasized the disruptive potential of the VERAFEYE™ system. He pointed out that the technology enables operators to utilize a single catheter for imaging and navigation while efficiently implementing their desired lesion sets. It essentially redefines procedural efficiency, achieving significant outcomes within an hour by combining the digital anatomy created by VERAFEYE™ with platforms like CardioFocus QuickShot™.

LUMA Vision's CEO, Fionn Lahart, described the completion of these procedures as a crucial milestone. The company’s vision remains focused on enhancing procedural accuracy and efficiency to ensure better patient outcomes. The VERAFEYE™ platform harnesses the power of advanced machine learning and AI, setting a new standard of care in cardiac procedures. Its ability to provide precise guidance during AF therapy represents only the initial steps towards broader applications in interventions like left atrial appendage closure.

The results of the study illustrate the potential of VERAFEYE™ to streamline procedure times while minimizing complications. Clinicians now have access to a dynamic and interactive depiction of the heart, allowing for improved anatomical accuracy during ablation operations.

Looking Ahead: The Future with LUMA Vision

Founded by Fionn Lahart and Christoph Hennersperger, LUMA Vision is dedicated to pioneering innovations in cardiac visualization and navigation. With its headquarters situated in Dublin, Ireland, the company is committed to transforming cardiac care globally. Through its cutting-edge technology, LUMA Vision aims to save lives and enhance healthcare by ensuring clinicians have the tools necessary to execute procedures with unprecedented precision. The company is optimistic about rolling out its technology on a larger scale in 2026, thereby impacting patient care positively across the globe.

In summary, LUMA Vision's achievements resonate within the medical community, paving the way for future innovations that prioritize patient care while advancing clinical standards in the realm of electrophysiology and structural heart interventions. As the organization continues its journey, it remains steadfast in its mission to redefine cardiac care through superior technology and collaborative efforts with healthcare professionals worldwide.